KoBioLabs, Inc (KOSDAQ:348150)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,835.00
-140.00 (-4.71%)
At close: Sep 3, 2026

KoBioLabs Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
14,6354,5945,68910,04710,43352,693
Short-Term Investments
32,52441,50150,14156,19482,51433,989
Trading Asset Securities
1,0061,006---2,003
Cash & Short-Term Investments
48,16547,10055,83066,24092,94788,685
Cash Growth
-2.45%-15.64%-15.72%-28.73%4.81%73.98%
Accounts Receivable
3,9523,9292,4131,858701.91199.2
Other Receivables
439.45601.29917.93,0204,2793,118
Receivables
4,3914,5313,3314,8784,9913,437
Inventory
7,4745,7104,4681,467977.47256.21
Prepaid Expenses
1,0511,332910.681,7651,8522,133
Other Current Assets
968.151,2642,1431,3781,7114,108
Total Current Assets
62,05059,93666,68275,729102,47898,619
Property, Plant & Equipment
28,14829,19431,17234,85820,4855,791
Long-Term Investments
-0-02,5602,48400
Other Intangible Assets
736.7774.39642.24637.67279.6324.2
Other Long-Term Assets
1,0931,3521,039914.62687.14541.7
Total Assets
92,02791,257102,096114,623123,930105,285

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
904.522.33.55---
Accrued Expenses
1,6971,8391,7561,127763.8543.31
Short-Term Debt
9,4006,0723,7918,6331,700-
Current Portion of Long-Term Debt
993.32917.943,83058.36-1,515
Current Portion of Leases
213.85245.4130.21234.21136.5124.6
Current Unearned Revenue
-257.84633.16775.09120.24632.53
Other Current Liabilities
5,1223,9993,67810,3236,2234,124
Total Current Liabilities
18,33113,33413,82221,1518,9446,840
Long-Term Debt
6,0756,4278,6719,17211,7657,633
Long-Term Leases
100.05106.45118.06195.96180.5324.37
Pension & Post-Retirement Benefits
-0-00-0-
Other Long-Term Liabilities
22,10522,12124,00722,2857,586200
Total Liabilities
46,61141,98946,61852,80428,47514,697

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
9,7099,7099,6879,4368,7228,135
Additional Paid-In Capital
215,454215,454215,260219,114220,581208,053
Retained Earnings
-178,254-174,455-168,125-162,827-148,975-127,053
Comprehensive Income & Other
-18,182-18,400-18,997-21,022-3,736577.08
Total Common Equity
28,72732,30937,82544,70276,59289,713
Minority Interest
16,59516,86617,55816,86818,132-
Shareholders' Equity
45,41749,26855,47761,81995,45590,589
Total Liabilities & Equity
92,02791,257102,096114,623123,930105,285

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
16,78213,76916,54018,29413,7829,197
Net Cash (Debt)
31,38333,33139,29047,94679,16579,488
Net Cash Growth
-12.04%-15.17%-18.05%-39.43%-0.41%56.20%
Net Cash Per Share
1616.151717.362046.852587.954713.304953.80
Filing Date Shares Outstanding
19.3919.4219.3718.8717.4416.27
Total Common Shares Outstanding
19.3919.4219.3718.8717.4416.27
Working Capital
43,71946,60352,86054,57893,53591,779
Book Value Per Share
1481.661663.771952.372368.654390.835513.80
Tangible Book Value
27,99031,53437,18344,06476,31289,388
Tangible Book Value Per Share
1443.671623.891919.222334.864374.805493.88
Land
6,4776,4776,4776,4776,477-
Buildings
14,39214,36414,30816,5635,925-
Machinery
11,25810,98110,8624,5693,920859.78
Construction In Progress
-70.1-8,7664,9295,321